| Immunogenic cell stress and death G Kroemer, C Galassi, L Zitvogel, L Galluzzi Nature immunology 23 (4), 487-500, 2022 | 586 | 2022 |
| Apoptotic cell death in disease—Current understanding of the NCCD 2023 I Vitale, F Pietrocola, E Guilbaud, SA Aaronson, JM Abrams, D Adam, ... Cell Death & Differentiation 30 (5), 1097-1154, 2023 | 122 | 2023 |
| Tuning cancer fate: tumor microenvironment's role in cancer stem cell quiescence and reawakening A Sistigu, M Musella, C Galassi, I Vitale, R De Maria Frontiers in immunology 11, 2166, 2020 | 73 | 2020 |
| Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B M Musella, A Guarracino, N Manduca, C Galassi, E Ruggiero, A Potenza, ... Nature immunology 23 (9), 1379-1392, 2022 | 59 | 2022 |
| The immune privilege of cancer stem cells: a key to understanding tumor immune escape and therapy failure C Galassi, M Musella, N Manduca, E Maccafeo, A Sistigu Cells 10 (9), 2361, 2021 | 48 | 2021 |
| Myeloid-derived suppressor cells and radiotherapy C Jiménez-Cortegana, C Galassi, V Klapp, DI Gabrilovich, L Galluzzi Cancer Immunology Research 10 (5), 545-557, 2022 | 45 | 2022 |
| Stress responses in stromal cells and tumor homeostasis I Vitale, G Manic, C Galassi, L Galluzzi Pharmacology & therapeutics 200, 55-68, 2019 | 31 | 2019 |
| The yin and yang of type I IFNs in cancer promotion and immune activation M Musella, C Galassi, N Manduca, A Sistigu Biology 10 (9), 856, 2021 | 30 | 2021 |
| Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51 G Manic, M Musella, F Corradi, A Sistigu, S Vitale, ... Cell Death & Differentiation 28 (7), 2060-2082, 2021 | 25 | 2021 |
| Microfluidic co-culture models for dissecting the immune response in in vitro tumor microenvironments A De Ninno, FR Bertani, A Gerardino, G Schiavoni, M Musella, C Galassi, ... JoVE (Journal of Visualized Experiments), e61895, 2021 | 14 | 2021 |
| The targeting of mre11 or rad51 sensitizes colorectal cancer stem cells to chk1 inhibition L Mattiello, S Soliman Abdel Rehim, M Musella, A Sistigu, A Guarracino, ... Cancers 13 (8), 1957, 2021 | 12 | 2021 |
| Using epigenetic modifiers to target cancer stem cell immunoevasion C Galassi, I Vitale, L Galluzzi Cancer Cell 39 (12), 1573-1575, 2021 | 9 | 2021 |
| Molecular determinants of immunogenic cell death elicited by radiation therapy C Galassi, V Klapp, T Yamazaki, L Galluzzi Immunological reviews 321 (1), 20-32, 2024 | 8 | 2024 |
| MDSCs sneak CSCs out of (immuno) surveillance C Jiménez-Cortegana, C Galassi, L Galluzzi Trends in Immunology 43 (1), 1-3, 2022 | 4 | 2022 |
| Assessment of IFN-γ and granzyme-B production by in “sitro” technology C Galassi, G Manic, M Musella, A Sistigu, I Vitale Methods in Enzymology 631, 391-414, 2020 | 4 | 2020 |
| Epigenetic escape of immunosurveillance by malignant cell precursors C Galassi, L Galluzzi The EMBO Journal 42 (10), e114050, 2023 | 2 | 2023 |
| Cytofluorometric assessment of cell cycle progression in irradiated cells C Jiménez-Cortegana, V Klapp, N Bloy, C Galassi, A Sato, T Yamazaki, ... Methods in Cell Biology 172, 1-16, 2022 | 2 | 2022 |
| Cytofluorometric assessment of acute cell death responses driven by radiation therapy B Álvarez-Abril, N Bloy, C Galassi, A Sato, C Jiménez-Cortegana, V Klapp, ... Methods in Cell Biology 172, 17-36, 2022 | 2 | 2022 |
| Cytofluorometric assessment of dendritic cell-mediated uptake of cancer cell apoptotic bodies M Musella, G Manic, C Galassi, I Vitale, A Sistigu Methods in Enzymology 632, 39-54, 2020 | 2 | 2020 |
| Immunologically relevant effects of radiation therapy on the tumor microenvironment C Galassi, V Klapp, SC Formenti, S Demaria, L Galluzzi Essays in biochemistry 67 (6), 979-989, 2023 | 1 | 2023 |
